Zepbound leads on reality: it is FDA-approved, prescribable, and available right now, while retatrutide remains in Phase 3 and cannot be legally filled for weight loss as of June 2026
Practical approaches include taking stairs instead of elevators, parking farther from destinations, standing while working when possible, and taking brief walking breaks every hour
However, its use in this specific patient population demands a personalized approach, careful monitoring, and ongoing research to fully understand its long-term effects
Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial